Cardiovascular Risk of Alcohol Consumption due to Renal Impairment: A 10-Year Prospective Study in a

Aya Hirata1, Sei Harada1, Miho Iida1

  • 1Department of Preventive Medicine and Public Health, Keio University School of Medicine.

Insights

Alcohol consumption increases cardiovascular disease (CVD) risk, especially with proteinuria. Renal impairment, particularly reduced kidney function, did not significantly alter this association in a large Japanese study.

Area of Science:

  • Cardiology
  • Nephrology
  • Public Health

Background:

  • Alcohol consumption is a known risk factor for cardiovascular disease (CVD).
  • The interplay between alcohol intake, CVD risk, and renal impairment is not fully understood.
  • Incorporating risk factors into health guidance is crucial for reducing harmful alcohol use.

Purpose of the Study:

  • To investigate the association between alcohol consumption and CVD risk in relation to renal status.
  • To determine if reduced estimated glomerular filtration rate (eGFR) or proteinuria modifies the alcohol-CVD risk relationship.

Main Methods:

  • A 10-year prospective study of 10,583 Japanese adults.
  • Alcohol intake categorized into five levels for men and four for women.
  • Cox proportional hazards models used to assess CVD risk, stratified by eGFR and proteinuria.

Main Results:

  • In men, alcohol intake was linked to higher atherosclerotic CVD risk with proteinuria, but inverse association without proteinuria.
  • Moderate to heavy drinking elevated intracerebral hemorrhage risk regardless of renal status.
  • In women, increased CVD risk from moderate to heavy drinking occurred only with proteinuria; reduced eGFR showed no clear effect.

Conclusions:

  • The cardiovascular disease risk associated with alcohol consumption is significantly influenced by the presence of proteinuria.
  • Reduced kidney function (eGFR) did not appear to substantially alter the relationship between alcohol and CVD risk.
Abstract

Related Concept Videos

Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
532
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
545
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
287
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
79
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
318